Jay T Flatley Denali Therapeutics Inc. (DNLI) insider trading activity

DNLI Quotes by TradingView

Jay T Flatley is Director of Denali Therapeutics Inc.. Currently has a direct ownership of 16,220 shares of DNLI, which is worth approximately $226,269. The most recent transaction as insider was on Jun 03, 2025, when has been sold 6,037 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.2K
59.29% 3M change
59.29% 12M change
Total Value Held $226,269

JAY T FLATLEY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 03 2025
BUY
Grant, award, or other acquisition
-
6,037 Added 27.12%
16,220 Common Stock
May 31 2024
BUY
Grant, award, or other acquisition
-
5,967 Added 36.95%
10,183 Common Stock

Also insider at

ILMN
ILLUMINA, INC. Healthcare
Director
RIVN
Rivian Automotive, Inc. Consumer Cyclical
Director
ZY
Zymergen Inc. Basic Materials
Chairman and Acting CEO
JTF

Jay T Flatley

Director
San Diego, CA

Track Institutional and Insider Activities on DNLI

Follow Denali Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNLI shares.

Notify only if

Insider Trading

Get notified when an Denali Therapeutics Inc. insider buys or sells DNLI shares.

Notify only if

News

Receive news related to Denali Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DNLI